Developing vaccines to prevent HIV infection
Official title: cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV
Funded at Advanced Bioscience Laboratories, INC. · NIH-11042023 · Data updated 2026-11-12
This study is working on making new vaccines to help prevent HIV-1 infection, and it could lead to better ways to protect people from the virus in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | November 10, 2023 |
| Project end | December 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,349,931 |
| NIH project number | 272201700010I-P00001-759302300001-1 |
| Project ID | NIH-11042023 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals at high risk of HIV exposure or those interested in preventive measures against HIV.
✕Less likely to help
Patients who are already living with HIV or those who are not at risk of HIV exposure may not receive direct benefits from this research.
What this research studies
This research focuses on creating and manufacturing vaccines aimed at preventing HIV-1 infection. It involves developing various types of vaccines, including DNA plasmids, viral vectors, and protein antigens, and conducting preclinical testing to ensure their safety and effectiveness. Patients may benefit from this research as it aims to produce vaccines that could eventually be tested in human clinical trials, potentially leading to new prevention methods against HIV. The research also includes maintaining quality control and regulatory documentation to support the transition to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the risk of HIV infection.
How similar studies have gone: Previous research has shown promise in developing vaccines for HIV, but this approach aims to enhance the efficiency and speed of vaccine production and testing.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.